DoubleLineome Solutions Fund (DoubleLineome Solutions Fund) Risk Assessment

View and export this data going back to 1985. Start your Free Trial

What is DoubleLineome Solutions Fund Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of DoubleLineome Solutions Fund is: No Data: Cannot be evaluated.

Competitive Comparison of DoubleLineome Solutions Fund's Risk Assessment

For the Asset Management subindustry, DoubleLineome Solutions Fund's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DoubleLineome Solutions Fund's Risk Assessment Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, DoubleLineome Solutions Fund's Risk Assessment distribution charts can be found below:

* The bar in red indicates where DoubleLineome Solutions Fund's Risk Assessment falls into.

DoubleLineome Solutions Fund (NYSE:DSL) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

DoubleLineome Solutions Fund Risk Assessment Related Terms

Thank you for viewing the detailed overview of DoubleLineome Solutions Fund's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

DoubleLineome Solutions Fund (DoubleLineome Solutions Fund) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » DoubleLine Income Solutions Fund (NYSE:DSL) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

2002 North Tampa Street, Suite 200, Tampa, FL, USA, 33602

Website

https://www.doublelinefunds.com

DoubleLine Income Solutions Fund is a closed-end fund. The fund's primary investment objective is to seek high income and its secondary objective is to seek capital appreciation. It invests in securities, including money market funds, foreign corporate bonds, us corporate bonds, bank loans, collateralized loan obligations, and municipal bonds. The portfolio of the fund consists of various industries such as Healthcare, Technology, Construction, Automotive, Insurance, Beverage, Pharmaceuticals, Leisure, and others.

Executives

Lisa Chen	officer: AML Compliance Officer	C/O DOUBLELINE FUNDS, 2002 NORTH TAMPA STREET, SUITE 200, TAMPA FL 33602
John C. Salter	other: Trustee	C/O DOUBLELINE CAPITAL LP, 2002 NORTH TAMPA STREET, SUITE 200, TAMPA FL 33602
Jose Sarmenta	officer: AML Officer	C/O DOUBLELINE CAPITAL LP, 333 SOUTH GRAND AVENUE, 18TH FLOOR, LOS ANGELES CA 90071
Joan Elam	officer: Dir of HR for DSL's Inv Adv	C/O DOUBLELINE CAPITAL, 333 SOUTH GRAND AVENUE, LOS ANGELES CA 90071
Robert Herron	officer: Vice President	C/O DOUBLELINE CAPITAL LP, 333 SOUTH GRAND AVENUE, LOS ANGELES CA 90071
Henry V Chase	other: See Remarks	C/O DOUBLELINE CAPITAL LP, 333 SOUTH GRAND AVENUE, 18TH FLOOR, LOS ANGELES CA 90071
Maria Theresa Walker	officer: Vice President	333 SOUTH GRAND AVE 18 FLOOR, LOS ANGELES CA 90071
Dawn Oswald	officer: Vice President	C/O DOUBLELINE CAPITAL LP, 333 SOUTH GRAND AVENUE, 18TH FLOOR, LOS ANGELES CA 90071
Youse Guia	officer: CHIEF COMPLIANCE OFFICER	C/O PIMCO, 650 NEWPORT CENTER DRIVE, NEWPORT BEACH CA 92660
Leticia A. Acosta	other: Adviser	333 SOUTH GRAND AVENUE, SUITE 1800, LOS ANGELES CA 90071
Adam D. Rossetti	officer: CHIEF COMPLIANCE OFFICER	333 SOUTH GRAND AVENUE, SUITE 1800, LOS ANGELES CA 90071
Winnie Han	officer: Assistant Treasurer	333 SOUTH GRAND AVENUE, SUITE 1800, LOS ANGELES CA 90071
Brady J. Femling	officer: Vice President	333 SOUTH GRAND AVENUE, SUITE 1800, LOS ANGELES CA 90071
James Charles Davison	other: Global Relationship Management	333 SOUTH GRAND AVE, 18TH FLOOR, LOS ANGELES CA 90071
Raymond Woolson	other: TRUSTEE	333 SOUTH GRAND AVENUE, 18TH FLOOR, LOS ANGELES CA 90071